Emcure Q1 FY27 earnings call scheduled for August 6, 2026

Board & Shareholder Meetings View source PDF

EMCURE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-0.4%1-day move

₹1792.00

prior close

₹1794.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.2-0.5-0.6-0.1-0.4+3.9+7.8+4.9+4.5+6.9————

Up moveDown movePending

AI summary

Emcure Pharmaceuticals has informed exchanges about an earnings conference call for investors and analysts on Thursday, August 6, 2026 at 4:00 PM IST. The call will cover unaudited standalone and consolidated financial results and performance for Q1 FY27, the quarter ended June 30, 2026. It will be held via Zoom Webinar, starting with management remarks followed by a Q&A session. The audio recording will be posted on the company website within 24 hours and the transcript within five working days after the call.

Likely market impact

Routine procedural filing. Investors should tune in for Q1 FY27 results and any management commentary on growth, margins, or business outlook.